Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache

Project: Research

Project Details

Project Description

multi-centre commercially sponsored clinical trial
Effective start/end date22/12/2224/07/24


  • Eptinezumab
  • Migraine
  • Medication overuse headache
  • Brief educational intervention
  • Migraine Disorders
  • Headache Disorders